Skip to content
Wednesday, April 15, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Congress removes deadline for Holocaust-looted art claims, setting stage for more restitution battles April 14, 2026
  • Hampshire College, incubator of Yiddish Book Center and a Holocaust-studies pioneer, to close April 14, 2026
  • Jewish food writer Joan Nathan knew her relative became a Catholic martyr. A search reveals the rest of his Holocaust history. April 14, 2026
  • Many children killed in the Holocaust had no one to say Kaddish for them. These Jews have stepped up. April 14, 2026
  • Israelis pause for a different kind of siren: the one marking Holocaust memorial day April 14, 2026
  • US funding for Israel’s Iron Dome air defense system used to enjoy bipartisan support. Not anymore. April 13, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.